Archives of Gynecology and Obstetrics

, Volume 285, Issue 1, pp 37–43 | Cite as

The implication of second-trimester amniotic fluid TNF-alpha, cytochrome C and cell death nucleosomes in the prediction of preterm labor and/or premature rupture of membranes

  • K. Puchner
  • C. Iavazzo
  • D. Gourgiotis
  • M. Boutsikou
  • S. Baka
  • D. Hassiakos
  • E. Kouskouni
  • E. Economou
  • A. Malamitsi-Puchner
  • G. Creatsas
Materno-Fetal Medicine

Abstract

Aim

The multifactorial pathway leading to preterm labor possibly includes the implication of apoptosis. This study aimed to clarify the role of amniotic fluid apoptotic molecules (TNF-alpha, cytochrome C and cell death nucleosomes) at midtrimester as possible predictors of preterm labor (PTL) and/or premature rupture of membranes (PROM).

Method

In this case–control study, comprising 360 women undergoing genetic amniocentesis and out of whom 38 delivered preterm and 18 out of the latter after PROM, the above apoptotic molecules were determined by ELISA. The 38 cases with PTL and 18 cases with PROM were matched for age with 38 and 18 respective controls delivering at term, and the levels of apoptotic molecules were compared.

Results

Cell death nucleosome levels were found to be significantly associated with preterm delivery. Specifically, for every unit increase in nucleosomes, women were on average 0.2% more likely to deliver preterm (OR: 1.002, CI: 1.0–1.003, p = 0.018). In contrast, such an association was not found concerning the other two apoptotic molecules (TNF-a and Cytochrome C).

Conclusion

Second-trimester amniotic fluid cell death nucleosomes’ levels are significantly associated with preterm delivery and could possibly serve as predicting markers.

Keywords

Apoptosis Cytokines Preterm delivery 

References

  1. 1.
    Ananth CV, Misra DP, Demissie K, Smulian JC (2001) Rates of preterm delivery among black women and white women in the United States over two decades: an age-period-cohort analysis. Am J Epidemiol 154:657–665PubMedCrossRefGoogle Scholar
  2. 2.
    Romero R, Salafia CM, Athanassiadis AP, Hanoaka S, Mazor M, Sepulveda W, Bracken MB (1992) The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 166:1382–1388PubMedGoogle Scholar
  3. 3.
    Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL (1992) A review of premature birth and subclinical infection. Am J Obstet Gynecol 166:1515–1528PubMedGoogle Scholar
  4. 4.
    Ananth CV, Vintzileos AM (2006) Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 19:773–782PubMedCrossRefGoogle Scholar
  5. 5.
    Romero R, Gotsch F, Pineles B, Kusanovic JP (2007) Inflammation in pregnancy its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 65:S194–S202PubMedCrossRefGoogle Scholar
  6. 6.
    Iavazzo C, Tassis K, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Hadjithomas A, Vrachnis N, Malamitsi-Puchner A (2009) Adrenomedullin concentration in second trimester amniotic fluid cannot be used as a predictor of preterm delivery. In Vivo 23(6):1021–1026PubMedGoogle Scholar
  7. 7.
    Iavazzo C, Tassis K, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Hadjithomas A, Botsis D, Malamitsi-Puchner A (2010) The role of human beta defensins 2 and 3 in the second trimester amniotic fluid in predicting preterm labor and premature rupture of membranes. Arch Gynecol Obstet 281(5):793–799PubMedCrossRefGoogle Scholar
  8. 8.
    Malamitsi-Puchner A, Vrachnis N, Samoli E, Baka S, Hassiakos D, Creatsas G (2006) Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth. J Soc Gynecol Investig 13:25–29PubMedCrossRefGoogle Scholar
  9. 9.
    Vrachnis N, Malamitsi-Puchner A, Samoli E, Botsis D, Iliodromiti Z, Baka S, Hassiakos D, Creatsas G (2006) Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery. J Soc Gynecol Investig 13:186–190PubMedCrossRefGoogle Scholar
  10. 10.
    McLean M, Bisits A, Davies J et al (1995) A placental clock controlling the length of human pregnancy. Nat Med 1:460–463PubMedCrossRefGoogle Scholar
  11. 11.
    Iavazzo C, Malamitsi-Puchner A (2010) Is there a positive or a negative role of second trimester amniotic fluid urocortin in preterm delivery prediction? Eur J Obstet Gynecol Reprod Biol 151(2):227–228PubMedCrossRefGoogle Scholar
  12. 12.
    Iavazzo C, Tassis K, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Vogiatzi C, Florentin-Arar L, Malamitsi-Puchner A (2009) Urocortin in second trimester amniotic fluid: its role as predictor of preterm labor. Mediators Inflamm 2009:947981PubMedCrossRefGoogle Scholar
  13. 13.
    Menon R, Fortunato SJ (2004) The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig 11(7):427–437PubMedCrossRefGoogle Scholar
  14. 14.
    Tanir HM, Sener T, Artan S, Kaytaz B, Sahin-Mutlu F, Ozen ME (2005) Programmed cell death (apoptosis) in placentas from normal pregnancy and pregnancy complicated by term (t) and preterm (p) premature rupture of membranes (PROM). Arch Gynecol Obstet 273(2):98–103PubMedCrossRefGoogle Scholar
  15. 15.
    Mahfouz RZ, Sharma RK, Said TM, Erenpreiss J, Agarwal A (2009) Association of sperm apoptosis and DNA ploidy with sperm chromatin quality in human spermatozoa. Fertil Steril 91(4):1110–1118PubMedCrossRefGoogle Scholar
  16. 16.
    El Khwad M, Pandey V, Stetzer B, Mercer BM, Kumar D, Moore RM, Fox J, Redline RW, Mansour JM, Moore JJ (2006) Fetal membranes from term vaginal deliveries have a zone of weakness exhibiting characteristics of apoptosis and remodeling. J Soc Gynecol Investig 13(3):191–195PubMedCrossRefGoogle Scholar
  17. 17.
    Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316(6028):552–554PubMedCrossRefGoogle Scholar
  18. 18.
    Maymon E, Ghezzi F, Edwin S, Mazor M, Yoon BH, Gomez R, Romero R (1999) The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 181:1142–1148PubMedCrossRefGoogle Scholar
  19. 19.
    Romero R, Manogue KR, Mitchell MD et al (1989) Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 161:336–341PubMedGoogle Scholar
  20. 20.
    Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J (1992) Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 166:1576–1587PubMedGoogle Scholar
  21. 21.
    Menon R, Lombardi S, Fortunato S (2002) TNF-® promotes caspase activation and apoptosis in human fetal membranes. J Ass Reprod Genet 19:201–204CrossRefGoogle Scholar
  22. 22.
    Fortunato SJ, Menon R, Swan KF (1994) Expression of TNF-alpha and TNFR p55 in cultured amniochorion. Am J Reprod Immunol 32:188–193PubMedGoogle Scholar
  23. 23.
    Pu J, Zeng WY (2009) Relationship among TNF-alpha gene promoter-308 site polymorphisms, the levels of maternal serum TNF-alpha, and the mRNA expression placental TNF-alpha in preterm labor. Sichnan Da Xue Xue Bao Yi Xue Ban 40:77–80Google Scholar
  24. 24.
    Wang XJ, Li L, Cui SH (2009) Role of collagen III CTGF and TNF-alpha in premature rupture of human fetal membranes. Sichnan Da Xue Xue Bao Yi Xue Ban 40:658–661Google Scholar
  25. 25.
    Rocha M, Hernandez-Mijares A, Garcia-Malpartida K, Bañuls C, Bellod L, Victor VM (2010) Mitochondria-targeted antioxidant peptides. Curr Pharm Des 16(28):3124–3131Google Scholar
  26. 26.
    Chai J, Xiong Q, Zhang P, Zheng R, Peng J, Jiang S (2010) Induction of Ca2+ signal mediated apoptosis and alteration of IP3R1 and SERCA1 expression levels by stress hormone in differentiating C2C12 myoblasts. Gen Comp Endocrinol 166(2):241–249PubMedCrossRefGoogle Scholar
  27. 27.
    Alberts Bruce (2002) Molecular biology of the cell, 4th edn. Garland Science, New York, p 207Google Scholar
  28. 28.
    Archer TK, Cordingley MG, Wolford RG, Hager GL (1991) Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol 11(2):688–698PubMedGoogle Scholar
  29. 29.
    Workman JL, Kingston RE (1992) Nucleosome core displacement in vitro via a metastable transcription factor-nucleosome complex. Science 258(5089):1780–1784PubMedCrossRefGoogle Scholar
  30. 30.
    Kornberg RD, Lorch Y (1999) Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98(3):285–294PubMedCrossRefGoogle Scholar
  31. 31.
    Iams JD, Paraskos J, Landon MB, Teteris JN, Johnson FF (1994) Cervical sonography in preterm labor. Obstet Gynecol 84:40–46PubMedGoogle Scholar
  32. 32.
    Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM (1996) The length of the cervix and the risk of spontaneous premature delivery. National institute of child health and human development maternal fetal medicine unit network. N Engl J Med 334:567–572PubMedCrossRefGoogle Scholar
  33. 33.
    Crane JM, Hutchens D (2008) Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol 31:579–587PubMedCrossRefGoogle Scholar
  34. 34.
    Canavan TP, Simhan HN, Caritis S (2004) An evidence-based approach to the evaluation and treatment of premature rupture of membranes: Part I. Obstet Gynecol Surv 59:669–677PubMedCrossRefGoogle Scholar
  35. 35.
    Galle PC, Meis PJ (1982) Complications of amniocentesis: a review. J Reprod Med 27:149–155PubMedGoogle Scholar
  36. 36.
    O’Brien WF (1984) Midtrimester genetic amniocentesis. A review of the fetal risks. J Reprod Med 29:59–63PubMedGoogle Scholar
  37. 37.
    Tabor A, Philip J, Madsen M, Bang J, Obel EB, Nørgaard-Pedersen B (1986) Randomised controlled trial of genetic amniocentesis in 4,606 low-risk women. Lancet 1:1287–1293PubMedCrossRefGoogle Scholar
  38. 38.
    Brumfield CG, Lin S, Conner W, Cosper P, Davis RO, Owen J (1996) Pregnancy outcome following genetic amniocentesis at 11–14 versus 16–19 weeks’ gestation. Obstet Gynecol 88:114–118PubMedCrossRefGoogle Scholar
  39. 39.
    Roper EC, Konje JC, De Chazal RC, Duckett DP, Oppenheimer CA, Taylor DJ (1999) Genetic amniocentesis: gestation-specific pregnancy outcome and comparison of outcome following early and traditional amniocentesis. Prenat Diagn 19:803–807PubMedCrossRefGoogle Scholar
  40. 40.
    Creasy RK (1993) Preterm birth prevention: where are we? Am J Obstet Gynecol 168:1223–1230PubMedGoogle Scholar
  41. 41.
    Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, Lockitch G (1995) Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 173:141–145PubMedCrossRefGoogle Scholar
  42. 42.
    Nelson KB, Grether JK (1999) Causes of cerebral palsy. Curr Opin Pediatr 11:487–491PubMedCrossRefGoogle Scholar
  43. 43.
    Shynlova O, Tsui P, Jaffer S, Lye SJ (2009) Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour. Eur J Obstet Gynecol Reprod Biol 144(Suppl 1):S2–S10PubMedCrossRefGoogle Scholar
  44. 44.
    Fortunato SJ, Menon R, Lombardi SJ (2001) Support for an infection-induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol 184(7):1392–1397PubMedCrossRefGoogle Scholar
  45. 45.
    Fortunato S, Menon R, Lombardi S (2002) Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 187:1159–1162PubMedCrossRefGoogle Scholar
  46. 46.
    Menon R, Lombardi SJ, Fortunato SJ (2002) TNF-alpha promotes caspase activation and apoptosis in human fetal membranes. J Assist Reprod Genet 9:201–204CrossRefGoogle Scholar
  47. 47.
    Romero R, Mazor M, Wu YK, Avila C, Oyarzun E, Mitchell MD (1989) Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua. Prostaglandins Leukot Essent Fatty Acids 37:183–186PubMedCrossRefGoogle Scholar
  48. 48.
    Park KH, Yoon BH, Shim SS, Jun JK, Syn HC (2004) Amniotic fluid tumor necrosis factor-alpha is a marker for the prediction of early-onset neonatal sepsis in preterm labor. Gynecol Obstet Invest 58:84–90PubMedCrossRefGoogle Scholar
  49. 49.
    Hitti J, Tarczy-Hornoch P, Murphy J, Hillier SL, Aura J, Eschenbach DA (2001) Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks’ gestation or less. Obstet Gynecol 98:1080–1088PubMedCrossRefGoogle Scholar
  50. 50.
    Menon R, Velez D, Morgan N, Lombardi S, Fortunato S, Williams S (2008) Genetic regulation of amniotic Xuid TNF-alpha and soluble TNF receptor concentrations aVected by race and preterm birth Hum. Genet 124:243–253Google Scholar
  51. 51.
    Lu LC, Hsu CD (1999) Elevated amniotic fluid nucleosome levels in women with intra-amniotic infection. Obstet Gynecol 94(1):7–10PubMedCrossRefGoogle Scholar
  52. 52.
    Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, Pappo O, Sulkes J, Neuman MG, Kaganovsky E, Kfir B, Tur-Kaspa R, Klein T (2003) Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J Intern Med 254(2):168–175PubMedCrossRefGoogle Scholar
  53. 53.
    Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Von Pawel J, Schalhorn A, Nagel D, Seidel D (2001) Circulating nucleosomes in serum. Ann N Y Acad Sci 945:93–102PubMedCrossRefGoogle Scholar
  54. 54.
    Fiscus RR, Leung CP, Yuen JP, Chan HC (2001) Quantification of apoptotic DNA fragmentation in a transformed uterine epithelial cell line, HRE-H9, using capillary electrophoresis with laser-induced fluorescence detector (CE-LIF). Cell Biol Int 25(10):1007–1011PubMedCrossRefGoogle Scholar
  55. 55.
    Kremer AE, Rust C, Eichhorn P, Beuers U, Holdenrieder S (2009) Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Rev Mol Diagn 9(2):139–156PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • K. Puchner
    • 1
  • C. Iavazzo
    • 1
  • D. Gourgiotis
    • 1
  • M. Boutsikou
    • 1
  • S. Baka
    • 1
  • D. Hassiakos
    • 1
  • E. Kouskouni
    • 1
  • E. Economou
    • 1
  • A. Malamitsi-Puchner
    • 1
  • G. Creatsas
    • 1
  1. 1.2nd Department of Obstetrics and Gynecology, Aretaieion HospitalUniversity of AthensAthensGreece

Personalised recommendations